Literature DB >> 29684365

Leukocyte Dynamics during the Evolution of Human Coronary Atherosclerosis: Conclusions from a Sevenfold, Chromogen-Based, Immunohistochemical Evaluation.

Melissa Zuiderwijk1, Marlieke Geerts1, Connie J van Rhijn1, Antoon van den Bogaerdt2, Jaap F Hamming1, Rogier A van Dijk1, Jan H Lindeman3.   

Abstract

Atherosclerosis is a complex process with strong inflammatory component. We developed a straightforward sevenfold staining protocol for simultaneous assessment of dominant leukocyte classes, vascularization, and expression of the putative foam cell maker CD36. The method was applied on human coronaries covering the full spectrum of atherosclerotic disease. Results confirm the progressive association of macrophages and T cells with the process and a global presence of mast cells. B cells are exclusively present in adventitial follicles that accompany the process plaque destabilization (thin cap and ruptured lesions) and are otherwise absent. Neutrophils are only present as part of the hemorrhage that accompanies plaque rupture. This study does not classify CD36 as a key factor in foam cell formation. Observed macrophage accumulation in the neointima of stabilized fibrous calcified plaques is consistent with a process of neoatherosclerosis. This study on human coronaries shows a progressive association of macrophage and T-cell abundance with plaque progression. Follicle-like structures are transiently present during the process of plaque destabilization. Plaque healing is accompanied by cessation of the inflammatory response but followed by a new cycle of atherosclerosis.
Copyright © 2018 American Society for Investigative Pathology. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29684365     DOI: 10.1016/j.ajpath.2018.03.011

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  1 in total

1.  Naoxintong Retards Atherosclerosis by Inhibiting Foam Cell Formation Through Activating Pparα Pathway.

Authors:  Zeng Wang; Huairui Shi; Huan Zhao; Zhen Dong; Buchang Zhao; Xinyu Weng; Rongle Liu; Xiao Li; Kai Hu; Yunzeng Zou; Aijun Sun; Junbo Ge
Journal:  Curr Mol Med       Date:  2018       Impact factor: 2.222

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.